Gürel, B.; Çapkın, E.; Parlar, A.; Özkan, A.; Çorbacıoğlu, M.; Dağlikoca, D.E.; Yüce, M.
Optimized Methods for Analytical and Functional Comparison of Biosimilar mAb Drugs: A Case Study for Avastin, Mvasi, and Zirabev. Sci. Pharm. 2022, 90, 36.
https://doi.org/10.3390/scipharm90020036
AMA Style
Gürel B, Çapkın E, Parlar A, Özkan A, Çorbacıoğlu M, Dağlikoca DE, Yüce M.
Optimized Methods for Analytical and Functional Comparison of Biosimilar mAb Drugs: A Case Study for Avastin, Mvasi, and Zirabev. Scientia Pharmaceutica. 2022; 90(2):36.
https://doi.org/10.3390/scipharm90020036
Chicago/Turabian Style
Gürel, Büşra, Eda Çapkın, Ayhan Parlar, Aylin Özkan, Meltem Çorbacıoğlu, Duygu Emine Dağlikoca, and Meral Yüce.
2022. "Optimized Methods for Analytical and Functional Comparison of Biosimilar mAb Drugs: A Case Study for Avastin, Mvasi, and Zirabev" Scientia Pharmaceutica 90, no. 2: 36.
https://doi.org/10.3390/scipharm90020036
APA Style
Gürel, B., Çapkın, E., Parlar, A., Özkan, A., Çorbacıoğlu, M., Dağlikoca, D. E., & Yüce, M.
(2022). Optimized Methods for Analytical and Functional Comparison of Biosimilar mAb Drugs: A Case Study for Avastin, Mvasi, and Zirabev. Scientia Pharmaceutica, 90(2), 36.
https://doi.org/10.3390/scipharm90020036